GB9611881D0 - Peptide derivatives - Google Patents

Peptide derivatives

Info

Publication number
GB9611881D0
GB9611881D0 GBGB9611881.5A GB9611881A GB9611881D0 GB 9611881 D0 GB9611881 D0 GB 9611881D0 GB 9611881 A GB9611881 A GB 9611881A GB 9611881 D0 GB9611881 D0 GB 9611881D0
Authority
GB
United Kingdom
Prior art keywords
peptide derivatives
peptide
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9611881.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Priority to GBGB9611881.5A priority Critical patent/GB9611881D0/en
Publication of GB9611881D0 publication Critical patent/GB9611881D0/en
Priority to GBGB9709607.7A priority patent/GB9709607D0/en
Priority to SK1667-98A priority patent/SK166798A3/en
Priority to JP10500312A priority patent/JP2000512277A/en
Priority to AT97924156T priority patent/ATE283278T1/en
Priority to KR10-1998-0710049A priority patent/KR100451522B1/en
Priority to CN97195216A priority patent/CN1130372C/en
Priority to IL12733297A priority patent/IL127332A0/en
Priority to BR9709533A priority patent/BR9709533A/en
Priority to TR1998/02537T priority patent/TR199802537T2/en
Priority to EP97924156A priority patent/EP0914333B1/en
Priority to DE69731747T priority patent/DE69731747T2/en
Priority to PL97330348A priority patent/PL330348A1/en
Priority to CA002252417A priority patent/CA2252417A1/en
Priority to NZ332347A priority patent/NZ332347A/en
Priority to US09/202,077 priority patent/US6541453B2/en
Priority to PCT/GB1997/001491 priority patent/WO1997046578A1/en
Priority to AU29720/97A priority patent/AU727757B2/en
Priority to HR970308A priority patent/HRP970308B1/en
Priority to TW086107849A priority patent/TW474947B/en
Priority to ZA9705037A priority patent/ZA975037B/en
Priority to ARP970102498A priority patent/AR008389A1/en
Priority to IDP971947A priority patent/ID17440A/en
Priority to NO985680A priority patent/NO985680L/en
Priority to US10/319,512 priority patent/US20030195158A1/en
Pending legal-status Critical Current

Links

GBGB9611881.5A 1996-06-07 1996-06-07 Peptide derivatives Pending GB9611881D0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GBGB9611881.5A GB9611881D0 (en) 1996-06-07 1996-06-07 Peptide derivatives
GBGB9709607.7A GB9709607D0 (en) 1996-06-07 1997-05-13 Peptide derivatives
AU29720/97A AU727757B2 (en) 1996-06-07 1997-06-03 Peptide derivatives
PL97330348A PL330348A1 (en) 1996-06-07 1997-06-03 Peptidic derivatives
CA002252417A CA2252417A1 (en) 1996-06-07 1997-06-03 Peptide derivatives
AT97924156T ATE283278T1 (en) 1996-06-07 1997-06-03 PEPTIDE DERIVATIVES
KR10-1998-0710049A KR100451522B1 (en) 1996-06-07 1997-06-03 Peptide derivatives
CN97195216A CN1130372C (en) 1996-06-07 1997-06-03 Peptide derivatives
IL12733297A IL127332A0 (en) 1996-06-07 1997-06-03 Peptide derivatives
BR9709533A BR9709533A (en) 1996-06-07 1997-06-03 Peptide derivative use and process for the production of the same pharmaceutical composition process for the treatment of an autoimmune or inflammatory disease mediated by mhc class ii dependent t-cell and protected or unprotected amino acid or a salt thereof
TR1998/02537T TR199802537T2 (en) 1996-06-07 1997-06-03 Peptide tèrevleri.
EP97924156A EP0914333B1 (en) 1996-06-07 1997-06-03 Peptide derivatives
DE69731747T DE69731747T2 (en) 1996-06-07 1997-06-03 PEPTIDE DERIVATIVES
SK1667-98A SK166798A3 (en) 1996-06-07 1997-06-03 Peptide derivatives, process for their preparation, pharmaceutical composition them containing, and their use
JP10500312A JP2000512277A (en) 1996-06-07 1997-06-03 Peptide derivative
NZ332347A NZ332347A (en) 1996-06-07 1997-06-03 Peptide derivatives containing a hydrophobic group, L-amino acid residues and modified L-amino acid residues
US09/202,077 US6541453B2 (en) 1996-06-07 1997-06-03 Peptide derivatives
PCT/GB1997/001491 WO1997046578A1 (en) 1996-06-07 1997-06-03 Peptide derivatives
HR970308A HRP970308B1 (en) 1996-06-07 1997-06-04 Peptide derivatives
TW086107849A TW474947B (en) 1996-06-07 1997-06-06 Peptide derivatives for use in the treatment of MHC class II dependent t-cell mediated autoimmune or inflammatory disease, pharmaceutical composition comprising the same, and process for manufacture of the same
ZA9705037A ZA975037B (en) 1996-06-07 1997-06-06 Peptide derivatives.
ARP970102498A AR008389A1 (en) 1996-06-07 1997-06-06 PEPTIDIC DERIVATIVES
IDP971947A ID17440A (en) 1996-06-07 1997-06-06 PEPTIDA'S DEMONSTRATIONS
NO985680A NO985680L (en) 1996-06-07 1998-12-04 peptide
US10/319,512 US20030195158A1 (en) 1996-06-07 2002-12-16 Peptide derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9611881.5A GB9611881D0 (en) 1996-06-07 1996-06-07 Peptide derivatives

Publications (1)

Publication Number Publication Date
GB9611881D0 true GB9611881D0 (en) 1996-08-07

Family

ID=10794873

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9611881.5A Pending GB9611881D0 (en) 1996-06-07 1996-06-07 Peptide derivatives

Country Status (2)

Country Link
GB (1) GB9611881D0 (en)
ZA (1) ZA975037B (en)

Also Published As

Publication number Publication date
ZA975037B (en) 1997-12-08

Similar Documents

Publication Publication Date Title
HRP970618A2 (en) Antiviral peptide derivatives
AP9700954A0 (en) 6-ohenylpyridyl-2-amine derivatives
AP9701156A0 (en) 6-phenylpyridyl-2-amine derivatives
HRP970308B1 (en) Peptide derivatives
IL125804A0 (en) Peptide derivatives
GB9624562D0 (en) Peptide derivatives
GB9604996D0 (en) Benzodiazonine derivatives
EP0850950A4 (en) Peptide derivatives
GR3035848T3 (en) Cyclic peptide derivatives
EP0861849A4 (en) Peptide derivatives
GB9603226D0 (en) Heterocyclyl-ergoline derivatives
GB9600063D0 (en) Guaridine derivatives
GB9702049D0 (en) Tetrahhydroisoquinoline derivatives
GB9603855D0 (en) Peptide derivatives
GB9709607D0 (en) Peptide derivatives
GB9611881D0 (en) Peptide derivatives
SI0882066T1 (en) Peptide derivatives
HU9601036D0 (en) Aryl-sulfonyl-hydroxamic-acid derivatives
GB9713361D0 (en) Peptide derivatives
AU2233497A (en) Peptide derivatives
GB9608430D0 (en) Peptides
GB9606765D0 (en) Peptides
GB9605904D0 (en) Peptides
GB9612648D0 (en) Peptides
GB9625227D0 (en) Peptides